Figure 4From: The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats Effects of fenofibrate and pioglitazone on osteoblast differentiation. Rat primary bone marrow cells were treated with increasing doses of PPAR agonists for 21 days and stained sequentially for ALP (A), calcium (B) and collagen (C). a = p < 0.05 compared with vehicle treated cells.Back to article page